Results 111 to 120 of about 60,470 (243)

Viral Detection and Clinical Disease Features in Pediatric Chronic Rhinosinusitis

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Objectives Chronic rhinosinusitis (CRS) results from complex host‐environment interactions with microbiome dysbiosis and viral infections postulated to drive inflammation and anatomic remodeling. This study investigates the impact of viral presence on pediatric sinonasal disease and clinical outcomes.
Mary C. Wilding   +7 more
wiley   +1 more source

α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke

open access: yes, 2016
Reena Berman, Di Jiang, Qun Wu, Hong Wei Chu Department of Medicine, National Jewish Health, Denver, CO, USA Abstract: Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (
Berman R, Wu Q, Jiang D, Chu HW
core  

Lipidomics Analysis of Rhinovirus Infection in Human Airway Epithelial Cells

open access: yes, 2017
Background: Rhinovirus is one of the most frequently detected respiratory viruses in adult patients with pneumonia or exacerbation of chronic lung diseases. Severe rhinovirus infection is increasingly recognized.
Dissanayake, DMTK   +6 more
core   +1 more source

Human Rhinovirus B and C genomes from rural coastal Kenya [PDF]

open access: yes, 2016
Primer-independent agnostic deep sequencing was used to generate three human rhinovirus (HRV) B genomes and one HRV C genome from samples collected in a household respiratory survey in rural coastal Kenya.
Nokes, D. James   +12 more
core   +1 more source

Lung Microbiome Diversity, Infection Dynamics, and Microbe‐Mediated Cross‐Protection

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
The protective role of the lung microbiome in maintaining respiratory health by promoting immune homeostasis, pathogen exclusion, and barrier integrity. Diverse microbial communities regulate immune maturation, enhance epithelial defenses, and contribute to antiviral responses, collectively preventing pathogen colonization and sustaining a balanced ...
Sana Arooj   +7 more
wiley   +1 more source

Human rhinovirus-c.

open access: yes, 2012
Discovery and genetic information on human rhinovirus ...
Chee, Hui Yee
core  

Organoids: From Bench to Bedside Applications

open access: yesMedComm, Volume 7, Issue 6, June 2026.
Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li   +6 more
wiley   +1 more source

Evidence‐based guideline for clinical practice in the diagnosis, treatment, management, and prevention of recurrent wheezing in infants and toddlers in China

open access: yesPediatric Investigation, Volume 10, Issue 3, Page 199-218, June 2026.
ABSTRACT Wheezing is a common respiratory symptom in infants and toddlers, and recurrent wheezing is a significant respiratory disorder affecting this age group. Given the multifactorial etiology of recurrent wheezing, clinical practice lacks standardized diagnostic and therapeutic protocols. Recent years have witnessed substantial progress in clinical
Committee of Pediatrics   +16 more
wiley   +1 more source

Nasal extracellular miRs profiles during rhinovirus infection.

open access: yes, 2016
(A) Scattered plot of nasal airway extracellular miRs (control vs. rhinovirus) airway show similar baseline miRNAnome (hsa-miR-630, hsa-miR-302d-3p, hsa- miR-320e, hsa-miR-612 miR) in rhinovirus (RV)-infected and control uninfected children except for ...
Geovanny F. Perez (2219266)   +11 more
core   +1 more source

Impact of RSV Preventive Strategies on Hospitalizations for Bronchiolitis in Infants

open access: yesPediatric Pulmonology, Volume 61, Issue 6, June 2026.
ABSTRACT Introduction Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and hospitalization in infants. Since 2023, France has implemented two preventive strategies aimed at reducing RSV burden: long‐acting monoclonal antibody nirsevimab and RSV vaccine for pregnant women, the latter becoming available from September 2024.
Marine Tarizzo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy